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ABSTRACT
The oligomerization state and mode of binding to
DNA of the GIY-YIG endonuclease II (EndoII) from
bacteriophage T4 was studied using gel filtration
and electrophoretic mobility shift assays with a set
of mutants previously found to have altered enzyme
activity. At low enzyme/DNA ratios all mutants
except one bound to DNA only as tetramers to
two DNA substrates. The putatively catalytic E118
residue actually interfered with DNA binding
(possibly due to steric hindrance or repulsion
between the glutamate side chain and DNA), as
shown by the ability of E118A to bind stably also
as monomer or dimer to a single substrate. The
tetrameric structure of EndoII in the DNA–protein
complex is surprising considering the asymmetry
of the recognized sequence and the predominantly
single-stranded nicking. Combining the results
obtained here with those from our previous in vivo
studies and the recently obtained crystal structure
of EndoII E118A, we suggest a model where EndoII
translocates DNA between two adjacent binding
sites and either nicks one strand of one or both
substrates bound by the tetramer, or nicks both
strands of one substrate. Thus, only one or two of
the four active sites in the tetramer is catalytically
active at any time.
INTRODUCTION
The GIY-YIG endonuclease II (EndoII) of coliphage T4,
encoded by gene denA, catalyzes the initial step in
host DNA degradation which causes irreversible host-
shutoﬀ and also initiates a nucleotide scavenge pathway
that provides precursors for phage DNA synthesis (1).
Phage DNA is protected from EndoII by substituting
hydroxymethylated cytosines for cytosines in its own
DNA (2,3). EndoII nicks DNA lacking cytosine modiﬁca-
tion at sites where only a CG base pair three positions
away from the scissile bond is strongly conserved (4).
Double-stranded cleavage by EndoII is the result of
concerted single-strand nicks (5), but even at cleavage
sites most often only one strand is nicked (4). EndoII
shares the sequence elements deﬁning the GIY-YIG
family of proteins (6,7) and residues previously implied
in catalysis by GIY-YIG enzymes as well as residues
conserved in the N-terminal region (NTR) and middle
region (MR) of EndoII are important in binding as well
as catalysis by this enzyme (4).
Two members of the GIY-YIG family of endo-
nucleases, each containing one copy of the GIY-YIG
motif (6), have been extensively characterized. The
homing endonuclease I-TevI binds as a monomer (8,9);
the nucleotide excision repair endonuclease UvrC is a
monomer in solution (10) and binds as a monomer at a
UvrB2 complex (11) at damaged DNA, though it can also
bind as a tetramer to any double-stranded DNA (12). In
addition to the GIY-YIG domain, these enzymes have
separate domains that confer most of the binding strength
and speciﬁcity. The GIY-YIG restriction endonucleases
Eco29kI and Cfr42I, like EndoII, are likely to lack separ-
ate DNA-binding domains. Eco29kI is a monomer in
solution (13) while its isoschizomer Cfr42I (32% sequence
identity) is a tetramer in solution, suggesting that the
enzyme also binds as a tetramer (14). These two restriction
endonucleases make double-stranded cuts within their
recognition sequence CCGC#GG. Hence, GIY-YIG
enzymes appear to apply a number of diﬀerent strategies
to bind to their recognition sequence, depending on add-
itional modules but also on variations in the GIY-YIG
module itself.
Analysis of a set of 13 EndoII mutants with reduced
catalytic capacity, permitting their overexpression and
puriﬁcation, has shown that all but one form strongly
retarded complexes with DNA in electrophoretic mobility
shift assays [EMSA (4)]. The exception is a mutant where
the conserved magnesium-coordinating and putatively
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yielding quite fast-moving complexes (4). We present here
an analysis of the oligomeric structure of EndoII and
its mode of binding to its substrate using some of these
mutants. The mutation K12A, located in the NTR, is pri-
marily important for stable binding to DNA, while the
mutation K76A, located in the MR, is important for
recognition as well as stable binding. Mutations of
strictly conserved GIY-YIG glycine and arginine residues,
G49A and R57A, cause altered sequence recognition
and poor binding, while mutation of the conserved glu-
tamate residue E118A in addition to permitting formation
of fast-moving enzyme-substrate complexes abolishes
catalysis (4).
Our analysis showed that all mutants investigated form
dimers and tetramers in solution and that the primary
enzyme–DNA complex most likely consists of a tetramer
binding to two DNA molecules. The catalytically inactive
E118A mutant additionally forms stable complexes
containing monomers and dimers bound to single DNA
molecules, suggesting that the wildtype glutamate residue
actually interferes with substrate binding.
MATERIALS AND METHODS
Strains and plasmids
EndoII was encoded by plasmids carrying the denA gene
in-frame with a PelB leader peptide (altogether 31-amino
acids) and six His residues at its N-terminus (15) (total
molecular mass 19.8kDa); constructs expressing E118A
and R57A were prepared also without the PelB leader
with only an MHHHHHH peptide at the N-terminus
of EndoII (total molecular mass 16.8kDa). Escherichia
coli BL21(DE3) pLysS (Novagen) was used for over-
expression of EndoII. Plasmids are listed in Supple-
mentary Table S1 of ref. (4). Plasmid DNA was puriﬁed
by Qiaprep Spin Miniprep Kit (Qiagen) and DNA
concentrations estimated by EtBr ﬂuorescence or using a
NanoDrop ND-1000 spectrophotometer (NanoDrop
Technologies).
Oligonucleotides, radiolabelling and polymerase
chain reaction
Oligonucleotides (Figure S1) were purchased from Sigma
Genosys. Radiolabelling and polymerase chain reactions
were carried out as previously described (4).
Preparation and activity assays of EndoII
Mutant EndoII was overexpressed from plasmids in vivo
and puriﬁed by aﬃnity chromatography, using HiTrap
Chelating HP columns charged with NiSO4 (Amersham
Pharmacia Biotech), eluting and desalting as previously
described (4). EndoII E118A and R57A concentrations
were determined using a BioRad protein assay with
bovine gamma globulin as standard; concentrations of
other mutant enzymes were determined by comparing
staining intensities of the EndoII bands in western blots
relative to those of diﬀerent amounts of EndoII R57A
analyzed on the same blot, as previously described (4).
Endo II nicking activity was assayed as previously
described (4).
Protein gels and western blots
Proteins were analyzed on discontinuous 5% (stacking)
14% (separating) sodium dodecyl sulfate polyacrylamide
gels (37.5:1, BioRad) with 0.025M Tris, 0.192M glycine,
0.1% SDS, pH 8.3 as running buﬀer. Gels were run in
a Mini protean II cell apparatus (BioRad) at 170V for
65min. After electrophoresis the gels were ﬁxed and
silver stained essentially as described by Oakley et al.
(16) and ﬁnally dried between cellophane sheets (for quali-
tative analysis), or transferred to Immobilon-P (Millipore)
transfer membranes and probed with monoclonal anti-
His6 antibody (Amersham) followed by secondary horse-
radish peroxidase-conjugated sheep anti-mouse IgG
antibodies (Amersham) and development with Enhanced
Chemical Luminescence reagent (Amersham) and expos-
ure to X-ray ﬁlm (for quantiﬁcation of EndoII, using
EndoII puriﬁed R57A as standard).
EndoII binding assay
EndoII binding was analyzed by electrophoretic mobility
shift assays (EMSA) as described (4), mixing varying
amounts of EndoII with substrate on ice in 10mM Tris–
HCl (pH 8.3 at room temperature), 5mM Na2EDTA,
30mM NaCl, 10% glycerol, 0.3mg/ml BSA in a ﬁnal
volume of 10ml and incubating at 308C for 15min
before electrophoresis at +48C on 5% (37.5:1) non-
denaturing polyacrylamide gels in 1  TEB pH 8.3. Long
substrates (148bp) were prepared by polymerase chain
reaction as described (4); shorter substrates were prepared
by annealing oligonucleotides, 30 or 44bp long, with the
807C cleavage site located in the middle (Supplementary
Figure S1). In experiments with two competing forms of
EndoII, these were mixed together before being added
to the substrate; in experiments with two competing
substrates these were mixed together before addition of
the enzyme.
In-gel cleavage
For in-gel cleavage, gel slices from EMSA gels were cut
out and soaked in cleavage buﬀer (4), which contains
10mM MgCl2, for 5–15min and then crushed with a
pipette tip and eluted overnight in 1mM Na2EDTA pH
8, 10mM NaCl. The samples were then analyzed by
electrophoresis in 15% polyacrylamide (37.5:1) gels
containing 7M urea in 1  TEB (4).
Gel filtration and crosslinking
Gel ﬁltration assays were run on SMART System from
Pharmacia at 48C. Ten to forty micrograms of enzyme in
20ml of 50mM sodium phosphate pH 7.9, 20% glycerol
and 10mM or 1M NaCl, with or without 1mgo f3 0 b p
substrate, was loaded on a Superdex 200 PC 3.2/30
column (Pharmacia Biotech) equilibrated in 50mM
sodium phosphate pH 7.9, 40 or 155mM NaCl (these
diﬀerences did not aﬀect the results) and 10% glycerol.
Samples with enzyme and substrate were incubated at
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gel ﬁltration. The eluate was collected in 25ml fractions.
For size determination the column was calibrated with
ribonuclease A, ovalbumin, aldolase and ferritin from
the Gel Filtration Calibration Kits (LMW or HMW)
(GE Healthcare). Crosslinking was performed with
bis[sulfosuccinimidyl]suberate (BS
3) (Pierce Biotechnology)
as described by the manufacturer except for using
10mM BS
3 for 15min.
RESULTS
EndoII forms dimers and tetramers in solution
Gel ﬁltration analysis showed that EndoII G49A with
PelB as well as R57A and E118A lacking PelB are pre-
sent as dimers in solution (Figure 1) under the low-
salt conditions used for our activity assay and EMSA
(4). Monomers formed a small fraction of the total
enzyme population (data not shown). At higher salt
concentrations also tetramers were formed (see
Figure 7); both EndoII dimers and the size standards
eluted at the same times at both salt concentrations.
Preferential formation of tetrameric EndoII at high-salt
concentrations is consistent with the crystal structure
of EndoII showing hydrophobic interactions in the
tetramerization interface (Andersson et al., manuscript
in preparation). The apparent sizes of the proteins were
 90–95% of what was expected for dimers and tetramers,
suggesting an enzyme slightly more compact than those
used for calibration. Peak fractions were subsequently
subjected to SDS–PAGE followed by Coomassie or
silver staining, with or without prior crosslinking with
BS
3. Crosslinked material from the fractions that were
expected to contain tetramers (gel ﬁltration at 1M NaCl
initial concentration) revealed monomers, dimers, trimers
and tetramers (Figure 2) conﬁrming the multimerization
of the enzyme. Material stuck at the top of the separating
gel may be aggregates. The occurrence of trimers, dimers
and monomers in the crosslinked tetramer material could
reﬂect instability of the tetramer (not all remaining tetra-
meric upon concluded gel ﬁltration) or incomplete pene-
tration of the crosslinking agent. The total intracellular
concentrations of cations in E. coli in vivo are quite
high,  220mM K
+ and  80mM Na
+ in exponentially
growing cells in media with approximately physiological
osmolarity (17), though some of these ions likely are
bound to various intracellular constituents. Thus, higher
order multimers of EndoII may be common in vivo.
EndoII needs >30bp for stable binding
Sites recognized by EndoII in vivo or in vitro are
characterized by a 16bp ambiguous sequence (15,18).
Although EndoII does nick a substrate where the
recognition site is embedded in a 24-bp oligonucleotide
duplex (5), this nicking is erratic and no stable gel shifts
were found with this substrate (data not shown),
suggesting that stable binding of EndoII requires more
DNA than the 16bp that are conserved around the
scissile bond. We prepared blunt-ended 30 and 44bp
substrates containing the same 23bp 807C core as the
previously used 148bp substrate (4) ﬂanked by random
GC-poor DNA (sequences shown in Supplementary
Figure S1), and tested them with diﬀerent EndoII
mutants.
The 44bp substrate was nicked reproducibly at the
same positions as previously found for the 807C site
(4,5) (data not shown), showing it is long enough to
function as substrate for EndoII. Also with this short
substrate, the E118A enzyme formed fast-moving
Figure 2. Analysis of crosslinked EndoII R57A and E118A lacking
PelB. Tetramer peaks from gel ﬁltered samples were collected and
crosslinked with BS
3. Equal amounts of crosslinked and non-
crosslinked samples (from the same peak fraction) were loaded on
SDS–PAGE and subsequently silver stained. Expected sizes: EndoII
monomer 16.8kDa, dimer 33.6kDa, trimer 50.4kDa and tetramer
67.2kDa. Lanes 1, 4 and 7, molecular weight standards, sizes in kDa
shown to the left; lane 2 R57A not crosslinked, lane 3 R57A
crosslinked with BS
3, lane 5 E118A not crosslinked, lane 6 E118A
crosslinked with BS
3.
Figure 1. Gel ﬁltration of EndoII G49A+PelB (black, thick line),
EndoII R57A–PelB (black, thin line) and E118A–PelB (gray) at
10mM initial NaCl concentration in the sample. The concentration
of NaCl in the column was 155mM. Separately ﬁltered size standards
were used to calibrate the column (elution times: ferritin, 440kDa,
29min; aldolase, 158kDa, 34min; ovalbumin, 43kDa, 40min; ribo-
nuclease A, 13.7kDa, 45min). The arrow points to the eluted dimer
with apparent sizes 37kDa for G49A+PelB (expected 39.6kDa);
33kDa for EndoII R57A–PelB and E118A–PelB (expected 33.6kDa).
The peak at 23min is the void.
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were absent with other mutants. The more slowly moving
complex C4 was formed by all mutants; some also formed
a slow-moving complex C3 in low amounts. Fewer com-
plex species were seen with these short substrates than
with the 148bp substrate previously used (4), as expected
since the 148bp substrate contains several more binding
sites. Binding of the two catalytically least active mutants,
E118A and R57A, was tested also in the presence of
10mM MgCl2 without EDTA, yielding essentially the
same EMSA patterns as in the absence of divalent cations
(data not shown).
Also the 30bp substrate was nicked at the same
positions (data not shown), but except for EndoII
E118A, enzyme quantities yielding stable complexes with
the 44bp substrate failed to do so for the 30bp substrate
(Figure 3A), showing that binding to this short substrate
was less stable. EndoII E118A, which we previously
identiﬁed as one of the best binding mutants (4), formed
complexes to the same extent with this substrate as with
the 44bp substrate. The mutant enzymes G49A and K76A
shifted the 30bp substrate when 20-fold more enzyme was
used (Figure 3A, lanes 17 and 19), while others, e.g. K12A
and R57A, did not produce distinct shifted bands even
with 50-fold higher enzyme concentration, (Figure 3A,
lanes 11 and 13).
In Figure 3B, formation of complexes with a less
eﬃciently nicked substrate was tested. Substrate 44M3
lacks the most prominent nick sites of the wt. 44bp sub-
strate (sites 2–4, Supplementary Figure S1), and was
nicked with about 5-fold lower eﬃciency by catalytically
proﬁcient EndoII K12A. The same complexes C1–C4 were
formed by EndoII E118A and complex C4 by G49A,
R57A and K12A with 44M3 as with wt. 44 (Figure 3B
and data not shown). Using standard conditions for bind-
ing and nicking assays, complex formation by the
cleavage-proﬁcient EndoII K12A to this variant substrate
was reduced to approximately the same extent as nicking,
while the catalytically inactive E118A mutant bound
equally well or better to this mutant substrate than to
the wt. substrate. When both assays were performed at
the same salt concentration (10mM NaCl), EndoII K12A
binding to the 44M3 substrate was less reduced than its
nicking of this substrate, in comparison to activities on
the wt. 44bp substrate. Thus, EndoII appears to be able
to bind to varying extent also to substrates that are not
nicked. This is supported by our observation that EndoII
can be chased out of its DNA complexes by poly(dAdT).
Enzyme titrations (Figure 4) showed that complexes C1
and C2 formed by EndoII E118A with the 30bp substrate
were chased into complexes C3 and C4, but no complex
moving more slowly than C4 was formed with this sub-
strate (Figure 4A, see also Figure 6B). In contrast, EndoII
E118A shifted the 44bp substrate from complexes C1 and
C2 into progressively more retarded complexes C3, C4
and C5. Complex C4 formed by EndoII R57A was simi-
larly chased into a more slowly moving complex C5 with
increasing enzyme concentration (Figure 4B). The most
retarded complexes C5 did not form until all the DNA
was bound by the enzyme.
AB
Figure 3. (A) EMSA with ﬁve representative mutant enzymes (K12A, G49A, R57A, K76A, E118A, all with the PelB leader) shifting the wt. 44bp
(lanes 1–5) or 30bp (lanes 6–20) substrates. Lanes 1–15 and 16–20 are from separate gels. Enzyme quantities in lanes 1–5 were chosen to produce
complexes with the 44bp substrate (3.7nM): K12A, 46nM; G49A, 45nM; R57A, 420nM; K76A, 272nM; E118A, 122nM. The same amounts of the
diﬀerent mutant enzymes that were used to shift the 44bp substrate in lanes 1–5 were also used with the 30bp substrate (3.7nM) in lanes 6–10. For
lanes 11–15, 50 times as much enzyme was used, and for lanes 16–20, 20 times as much enzyme was used. C1–C4 indicate positions of diﬀerent
enzyme–DNA complexes. (B) EMSA with EndoII E118A and K12A on 44bp substrates having (44wt.) or lacking (44M3, see Supplementary
Figure S1) preferred nick sites. The same molar ratios of the respective enzymes to substrate were used as for panel A, lanes 1–10. Numbers below
the lane numbers show relative eﬃciency of complex formation (at standard binding conditions, 30mM NaCl) and relative nicking eﬃciency
(at standard nicking conditions, 1mM NaCl). Lanes 1–3 and 4–5 are from diﬀerent portions of the same gel.
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and an EndoII monomer or dimer
EndoII of two diﬀerent sizes [with or without the PelB
leader, which does not aﬀect recognition or catalysis by
EndoII (4,15), 19.8 and 16.8kDa, respectively] were used
to determine the nature of the fast-moving complexes seen
with the E118A mutant. Gel shifts were performed with
the two forms of EndoII separately and mixed (Figure 5),
in amounts that would shift similar fractions of the
substrate. As expected, the larger enzyme (carrying the
leader peptide) produced more slowly moving complexes
than the smaller enzyme (lacking the leader peptide)
(compare lanes 1 and 4 with lanes 3 and 6, respectively).
If the same bands are formed in the mixed reaction as
in the separate reactions, this would indicate that only
one molecule of EndoII was bound to the substrate
in these bands. An additional intermediate band, not
corresponding to any of the bands in the separate
reactions, would indicate a mixture of two enzymes
bound to the substrate, one of each size. In the region of
complex C1, a mixture of the two E118A enzymes (lane 2)
with the 44bp substrate produced the same two bands as
seen separately in lanes 1 and 3. Thus, this complex
contains only one EndoII monomer per DNA. In the
region of complex C2, an intermediate band could be
seen, suggesting that this complex contains one dimer
(or two monomers) per DNA. The 30bp substrate gave
the same results (lanes 4–6).
We also used the 30 and 44bp substrates together to
verify the number of DNA molecules in the E118A
complexes. In the region of complex C1 two bands
formed from the mixed substrates (Figure 5, lane 7),
corresponding to the bands seen separately with only
one substrate (lanes 6 and 8). Thus, only one DNA mol-
ecule is present in complex C1. Complexes C2 (as well as
C3 and C4) with 30 or 44bp DNA migrated largely at the
same rate regardless of substrate length (lanes 6–8),
preventing determination of their DNA content by this
method. Instead a cold, 148bp substrate was used to
compete the radiolabelled 44bp substrate (44 ). If only
one DNA molecule was included in each complex, the
complexes containing 44  bp DNA would still migrate at
the same rate while the complexes containing unlabelled
148bp DNA would not be visible on the autoradiogram.
With increasing amounts of unlabelled competitor, the 44 
bp substrate would be competed out of its complexes. On
the other hand, if the complexes contain more than one
DNA molecule, those containing both substrates (44  and
148bp DNA) should be visible on the gel and be signiﬁ-
cantly more retarded than those containing only 44  bp
DNA molecules. Since there is more than one EndoII
binding site in the 148bp substrate (4), larger complexes
could form with, for example two or three 44  bp sub-
strates bound to the same 148bp molecule.
Results from these competition experiments with
EndoII E118A are shown in Figure 6A. At a molar
Figure 5. EMSA analysis of wt. 30bp and wt. 44bp substrates with
E118A   the PelB leader. The substrates were 44bp (lanes 1–3, 8–9;
3.7nM) or 30bp (lanes 4–6, 10; 5.4nM), or both together at these
concentrations (lane 7). Enzyme preparations were E118A with or with-
out the PelB leader, in quantities shifting approximately the same frac-
tion of the added substrate (actual fractions shifted are noted below the
lane numbers). For lanes 2 and 5 mixtures of the preparations with and
without PelB were used. No enzyme was added for lanes 9 and 10.
Arrows C1–C4 indicate the diﬀerent enzyme–DNA complexes formed.
Bands formed by combinations of enzyme with or without PelB in the
C2 area of lane 2 are shown with arrows (+, with PelB;  , without
PelB). In the areas denoted C3 and C4 several diﬀerent complexes can
be seen, but are not well resolved in these gels.
AB
Figure 4. EMSA titration of EndoII mutants with PelB. (A) EndoII
E118A and the wt. 30bp substrate. Lane 1, no enzyme; lanes 2–6, 6.6,
26, 104, 415nM; and 1.66mM EndoII E118A per lane; all lanes, 3.7nM
of the wt. 30bp substrate. C1–C4 indicate positions of diﬀerent
enzyme–DNA complexes. The smear above the C2 band at high
enzyme concentrations is likely caused by degradation products from
higher-order complexes. (B) EndoII E118A and R57A and the wt.
44bp substrate. Lanes 1 and 7, no enzyme added. Lanes 2–6, the
same amounts of EndoII E118A as for lanes 2–6 in (A); lanes 8–12,
23, 91, 367nM, 1.46 and 5.86mM EndoII R57A per lane; all lanes,
3.7nM of the wt. 44bp substrate. C1–C5 indicate positions of diﬀerent
enzyme–DNA complexes. Panels A and B are from diﬀerent gels.
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the fast-moving complexes C1 and C2 were formed
(lanes 2–5). Addition of the competitor did not result in
altered migration rates for these complexes, conﬁrming
that they only contain one DNA molecule each.
Slow-moving complexes contain more than one DNA
molecule and more EndoII than one dimer
Since complexes C1 and C2 could be chased into C3 and
C4 with progressively more enzyme added (Figure 4B),
these slow-moving complexes must contain more EndoII
than one dimer. Using higher molar ratios EndoII E118A/
44  bp substrate of 110:1 or 450:1 virtually all of the
substrate was found in the slow-moving complexes C4
and C5 (Figure 6A, lanes 6 and 10). When the 148bp
substrate was added to these complexes (lanes 7–9, 11–
13) additional complexes with increased migration rate
were formed. Complex C5 disappeared completely even
with the lowest amount of competitor, and since the
amount of faster-moving material did not increase in
proportion, at least some of the label in this complex
must be present in the newly-formed slow-moving
complexes in lane 7. Thus, complex C5 must contain
more than one DNA molecule. The nature of complex
C4 was more diﬃcult to elucidate from this experiment.
Figure 6B, however, shows that also complex C4 contains
more than one DNA molecule: EndoII E118A formed no
more slowly moving complexes than C4 with the 30bp
substrate (Figure 4A and 6B, lane 7), and this was
chased into larger complexes with increasing amounts of
148bp competitor. [The lack of complex C1 in Figure 6B
is a consequence of the enzyme concentration used (cf
lanes 6 and 7 in Figure 4A)]. A competition experiment
with EndoII G49A, shown in Figure 6C, showed that also
with this mutant complexes C4 and C5 gave rise to more
slowly migrating complexes in the presence of the com-
petitor (lanes 3–6 and 9–12, respectively), suggesting they
both contain more than one DNA molecule.
It is not likely that two DNA molecules in a complex
are held together by two separate EndoII dimers; in that
case both dimers must bind both substrate molecules
which means that complexes containing two DNA
molecules held together by one dimer should also be
present. The presence of 50% more DNA shifts the C2
complex marginally (cf. lanes 6 and 8 in Figure 5). Thus,
the presence of 100% more DNA (two substrate molecules
per dimer) should result in a complex migrating at
approximately the same rate as C2 for all mutants, for
which we see no evidence. Thus cooperativity in binding
(an enzyme that has already bound DNA recruiting an
AB C
Figure 6. EMSA analysis of EndoII E118A (with PelB) binding to competing substrates. A, B and C are from diﬀerent gels. (A) Radiolabelled wt.
44bp substrate (1ng; 3.7nM) was competed by increasing amounts of cold 148bp substrate for binding to EndoII E118A. Lane 1, no enzyme added;
lanes 2, 6 and 10, no 148bp substrate added. Lanes 2–5, 100nM EndoII E118A; lanes 6–9 410nM EndoII E118A; lanes 10–13, 1.66mM EndoII
E118A. Of the competitor 148bp substrate, 1.7ng (1.9nM) was added for lanes 3, 7 and 11; 3.4ng (3.8nM) for lanes 4, 8 and 12; and 33.6ng
(37.4nM) for lanes 5, 9 and 13. C1–C5 indicate positions of diﬀerent enzyme–DNA complexes; drawings to the left indicate probable compositions
of the complexes. (B) Radiolabelled wt. 30bp substrate (5.4nM per assay) was competed by increasing amounts of cold 148bp substrate for binding
to EndoII E118A. Lane 1, no enzyme added; lanes 2 and 7, no 148bp substrate added. Lanes 2–6, 1.95mM EndoII E118A per lane; lane 7, 31.2mM
EndoII E118A. Of the competitor 148bp substrate, 1.7ng (1.9nM) was added for lane 3; 3.4ng (3.8nM) for lane 4; 8.4ng, 9.3nM for lane 5; and
33.6ng (37.4nM) for lane 6. C2 and C4 indicate positions of diﬀerent enzyme–DNA complexes. (C) EMSA analysis of EndoII G49A (with PelB)
binding to competing substrates of diﬀerent sizes. Radiolabelled wt. 44bp substrate (1ng per assay; 3.7nM) was competed by increasing amounts of
cold 148bp substrate for binding to EndoII G49A. Lanes 1 and 7, no enzyme added; lanes 1, 2, 7 and 8, no 148bp substrate added. Lanes 2–6,
43nM EndoII G49A per lane; lanes 8–12, 2.26mM EndoII G49A per lane. Of the competitor 148bp substrate, 1.7ng (1.9nM) was added for lanes 3
and 9; 3.4ng (3.8nM) for lanes 4 and 10; 8.4ng (9.3nM) for lanes 5 and 11; and 33.6ng (37.4nM) for lanes 6 and 12. C4 and C5 indicate positions
of diﬀerent enzyme–DNA complexes.
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unlikely. As a further test for cooperativity in binding,
binding assays were carried out with all mutants at
varying enzyme/substrate ratios, using the 148bp
substrate. The fraction of complexed DNA increased
linearly with enzyme/substrate ratios in titrations yielding
from 5 to 90% of the substrate complexed, suggesting
there was no cooperative binding by EndoII. Thus, the
EndoII species forming complex C4 must be present in
solution and bind as one unit—a trimer, tetramer or
higher order complex—to the substrate.
Using the 44bp substrate and soaking gel slices in cleav-
age buﬀer, complexes formed with the nicking-proﬁcient
K12A mutant enzyme were found to be catalytically active
(data not shown). About 80% of the EndoII K12A
C4-complexed 44bp substrate was nicked after 15min
in-gel incubation with MgCl2 at room temperature. This
suggests that both substrates bound in C4 are nicked.
However, in-gel dissociation and association (19) could
produce complete nicking even if each complex nicks
only one of the bound substrates.
Complex C3 never accounts for more than a small
fraction of the total DNA added, making it diﬃcult to
elucidate its composition. It is not likely to be a dimer
with two bound substrate molecules, since this would
be expected to move almost as fast as complex C2.
Preliminary results comparing the DNA content with the
enzyme content in the C3 and C4 bands suggest that there
is less enzyme per DNA in the C3 band than in the C4
band, so possibly C3 consists of two substrate molecules
with an EndoII trimer or a dimer plus a monomer
(implying C4 is at least a tetramer). Also the precise com-
position of complex C5 is elusive. Since the migration rate
of the fast-moving C2 complex was not measurably
aﬀected by a 50% diﬀerence in the amount of bound
DNA (30 versus 44bp, Figure 5), a diﬀerence between
C4 and C5 just in the amount of DNA is unlikely.
Complex C5 therefore must contain more EndoII than
C4; it may also contain more DNA.
Complex C4 most likely consists of an EndoII tetramer
binding two DNA molecules
To analyze the nature of the slow-moving EndoII-DNA
complexes, gel ﬁltration was performed. Since the 44bp
substrate migrated at the same rate as the enzyme
tetramer, the R57A mutant did not bind well to the
30bp substrate (Figure 3) and the E118A mutant likely
would cause a very complex pattern, the G49A mutant
and the 30bp substrate were chosen. Results are shown
in Figure 7. The 30bp substrate migrated at a rate in
between those for dimeric and tetrameric EndoII,
corresponding to a protein molecular mass of 52kDa.
When the enzyme had been permitted to interact with
the 30bp substrate, a new peak appeared, migrating at a
rate corresponding to a protein with molecular mass of
170kDa. This is consistent with an EndoII tetramer
bound to two DNA molecules (apparent size expected
from gel ﬁltration of tetramer and DNA separately
179kDa). The molar enzyme/substrate ratio in this experi-
ment was 42:1. From the analysis in Figure 3 (lanes 12
and 17), a molar ratio EndoII G49A/30bp substrate
higher than 240:1 is needed to produce signiﬁcant
quantities of complexes moving more slowly than C4.
Thus, the complex seen in the gel ﬁltration most likely is
complex C4. Increasing the enzyme–substrate ratio in gel
ﬁltration experiments did not result in the formation of a
peak of a faster-eluting complex corresponding to C5, but
only increased the amount of enzyme in the void,
suggesting that the C5 complex is too large to enter
these beads. At lower enzyme–substrate ratios than the
one shown, less and less of the shown complex was
formed but no new peaks appeared between that of this
complex and that of free enzyme.
DISCUSSION
Tetrameric EndoII binds to two substrates
For all mutants tested, except EndoII E118A, complex C4
was the only species formed at low enzyme/DNA ratios.
Since these mutants carry very diﬀerent substitutions
aﬀecting their catalytic activities in diﬀerent ways, we con-
sider it likely that this complex is representative also for
the wildtype enzyme. EMSAs, gel ﬁltration experiments
and crosslinking studies suggest that complex C4 contains
two DNA molecules to which an EndoII tetramer is
bound.
In the gel ﬁltration assays, free native EndoII was
recovered primarily as dimers under the low ionic strength
conditions used for activity and gel shift assays, and as
dimers and tetramers at higher ionic strength (Figures 1
and 7 and data not shown). The EndoII E118A mutant
also crystallizes as a tetramer formed by two primary
Figure 7. Gel ﬁltration of the 30bp substrate (thin grey line), and of
EndoII G49A carrying the PelB leader incubated with the wt. 30bp
substrate (molar ratio of monomeric enzyme to substrate 42:1) at
10mM (thick black line) and without the substrate at 1M (thin black
line) initial NaCl concentration in the sample. The concentration of
NaCl in the column was 40mM in all cases. Arrows point to eluted
EndoII complexes: 2, apparent size 35kDa (expected for EndoII
G49A+PelB dimer 39.6kDa); 4, apparent size 74.7kDa (expected for
tetramer 79.2kDa). C indicates the enzyme–DNA complex with appar-
ent size 170kDa. The apparent size of the 30bp substrate corresponded
to a protein of 52kDa. The peak at 22min is the void.
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(Andersson et al., manuscript in preparation). It is
unlikely that tetramerization is induced upon binding to
the substrate, since this should have resulted in a coopera-
tive binding pattern, of which we see no evidence. We
suggest that only the tetramer can bind stably to DNA,
and, as free tetramers are removed from the solution, new
free tetramers will be formed from the free dimers to main-
tain the dimer–tetramer equilibrium.
The effect of Glu118 on binding
Diﬀerent from all other mutants, EndoII E118A formed
fast-moving complexes C1 (one copy of EndoII, one DNA
molecule) and C2 (two copies of EndoII, one DNA
molecule). EndoII E118A also was the only mutant bind-
ing equally well to substrates lacking eﬃciently utilized
nick sites. The 16bp EndoII site is located in the middle
of the 30bp substrate, and the active surface of EndoII
(as modelled on UvrC (4) and seen in the EndoII E118A
crystal) is 10bp across. This leaves room for one enzyme
molecule binding to the recognized sequence, either one
EndoII monomer or half of one dimer. Binding of two
monomers would force one or, more likely, both of
them to bind outside of the recognition sequence, resulting
in a less stable complex. Only a mutant binding more pro-
miscuously would be expected to form stable complexes
also outside the recognition sequence. At low enzyme/
substrate ratios (Figure 4A and B, lane 3), complex C2
formed a sharp band indicating a unique composition;
according to the reasoning above, we consider it most
likely that this complex is formed by an EndoII dimer
rather than two monomers.
Thus, EndoII E118A binds to single DNA molecules
both in monomeric and in dimeric form, as well as to
two substrate molecules simultaneously in the tetrameric
form that was found with all other mutants. The E118A
mutant enzyme did not seem to be compromised in its
ability to form dimers or tetramers, since the free
enzyme in solution was found in these forms in similar
proportions as for other mutants, as shown by both gel
ﬁltration and crosslinking experiments. Thus, the diﬀer-
ence between EndoII E118A and all other variants likely
lies in its interaction with DNA, not in its multimerization
capacity.
The E>A substitution removes a negative charge at
the catalytic surface, which may aﬀect binding directly.
Alternatively, the glutamate may coordinate residues else-
where in the same monomer or primary dimer in a way
that actually reduces binding e.g. through steric hindrance
or by aﬀecting the structure of the dimer. Removing such
interactions may facilitate binding to the substrate, though
not necessarily in a manner permitting eﬃcient catalysis.
Such facilitated binding might explain why EndoII E118A
can bind single substrates stably, both as monomer and
dimer. Conversely, the need for a tetramer for stable bind-
ing may reﬂect a need for more interaction surface than
provided by a monomer or dimer to generate suﬃcient
binding energy for wildtype-like enzymes.
EndoII E118A also failed to produce complexes moving
more slowly than C4 with the 30bp substrate, though it
produced complex C5 with the 44bp substrate. The other
mutants that formed complexes with the 30bp substrate at
reasonable enzyme concentrations (G49A and K76A)
both produced complexes moving more slowly than
C4 with this substrate. Both these mutants, however,
show reduced base-speciﬁed contacts, especially at the
distal parts of the recognized sequence (4), and therefore
may bind more promiscuously to a shorter sequence,
permitting them to load more than one tetramer on to
the short 30bp substrate.
Comparison to other endonucleases
A tetrameric complex was quite unexpected for EndoII,
which recognizes a long and asymmetric DNA sequence
(15,18,20) with relatively low sequence speciﬁcity. Proteins
that bind to DNA as dimers or tetramers often recognize
symmetric DNA sequences [e.g. (21–23)] or structures
(24). Some restriction endonucleases that require two
DNA recognition sites are related to recombinases and
transposases, DNA binding proteins that bring distant
DNA sites together [e.g. EcoRII (25); NaeI (26)], while
others carry out recombination-like functions [type IIF
enzymes catalyzing four-strand DNA breakage, e.g. SﬁI
(27)]. Among enzymes that cleave within their recognition
sequence and bind to two DNA sites simultaneously,
restriction endonucleases of type IIE (e.g. EcoRII, NaeI)
engage their two targets using two separate and distinct
domains (28,29), which distinguishes these enzymes from
the homotetrameric EndoII. Type IIF restriction endo-
nucleases (e.g. SﬁI, Bse634I, SgrAI) cleave both targets
coordinately (30). The majority of these endonucleases
are homotetramers arranged as dimers of dimers, where
each dimer binds and cleaves one copy of the target site
(31,32). SgrAI may bind as a dimer to one DNA site,
subsequently recruiting another dimer bound to another
site forming a tetramer binding two DNA sequences (33);
this is unlikely for EndoII as we see no complexes of
dimeric EndoII to single DNA substrates (except in the
special case of EndoII E118A, which is addressed above).
Instead, the most likely scenario is that EndoII binds as a
tetramer [dimer of dimers, as the type IIF enzyme Bse634I
(34)]. Types I, IIB, IIS, III and IV restriction endo-
nucleases usually interact with two DNA sites (35–39).
However, all ﬁve types cleave DNA outside their recogni-
tion sequence, and types I, III and IV also diﬀer signiﬁ-
cantly from EndoII in subunit organization and cofactor
requirement.
The two investigated GIY-YIG restriction endo-
nucleases Eco29kI and Cfr42I like EndoII bind their
substrates without cation cofactor and require a metal
ion cofactor for all catalytic events (14,40), but in contrast
to EndoII recognize and cleave short, symmetric unam-
biguous sequences. Cfr42I presumably binds as a tetramer
to two DNA molecules (14) while Eco29kI is a monomer
in solution (13). The sequence similarity between EndoII
and these two GIY-YIG restriction endonucleases is
very low outside the conserved GIY-YIG motifs,
preventing reliable alignments; manual alignment suggests
some similarities in the NTR. The sequence recognized
by EndoII is more similar to that of the homing
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isoschizomer I-BmoI (8,41), which however bind as
monomers and nick one of the strands in the absence of
Mg
2+ (9,42). Thus, EndoII is unique among sequence-
speciﬁc GIY-YIG endonucleases in its interactions with
its substrate.
Mechanism of EndoII activity
EndoII recognizes an asymmetric ambiguous sequence
and shows varying catalytic activity depending on the
exact DNA sequence at the site. Stable catalytic complexes
are formed only after the tetrameric enzyme has bound
two DNA substrates. Comparison of results obtained
in vivo and in vitro suggests that catalysis involves either
nicking on one strand only (mode I activity) or cleavage
due to simultaneous nicking of both strands (mode II
activity). Also mode I activity can result in double-
stranded cleavage upon consecutive (more than one bind-
ing event) rather than concurrent (one binding event)
nicks, but this activity is masked in vivo by the action of
repair functions that seal single-stranded nicks. In vitro,
both modes can be observed, but mode I activity is higher
(5). In vivo, only mode II activity can be observed since
nicks are rapidly sealed (5). A GC-rich sequence element
centred four base pairs to one side of the incised position
is shared in both catalytic modes; mode II activity in add-
ition requires a second sequence element centred 2bp to
the other side (4,18). In mode I activity, both bound
substrates may be nicked, since in-gel activity on the
44bp substrate by EndoII K12A in complex C4 exceeded
50%. However, in-gel dissociation and association (19)
could result in complete nicking even if only one substrate
is nicked by each tetramer.
Mode II activity appears to be eﬃcient only at one of
the two bound sites (20). With long substrates, the two
DNA sites bound by each tetramer likely are part of the
same DNA molecule looped between the binding sites or
searched via intersegment transfer, since the eﬀective con-
centration of a site present in cis will be higher than that
for a site present in trans. In support of a scanning
mechanism, as little as 3–9% modiﬁed Cyt (glucosyl-
hydroxymethylated) residues in the DNA, resulting in ap-
proximately one modiﬁed residue per 60bp, completely
prevents EndoII cleavage in vivo (43). We propose that
upon binding of one site to one part (one dimer) of the
EndoII tetramer, the DNA is translocated by the second
dimer until it reaches a second site. If a modiﬁed Cyt is
encountered during translocation the enzyme may be
dissociated from its substrate, or a catalytically inactive
complex may be formed. If no modiﬁed residue is
encountered, the second dimer may bind the second site
reached, resulting in formation of a catalytically proﬁcient
complex. When a preferred EndoII cleavage site was
introduced into the substrate, in vivo cleavage (mode II
activity) at neighbouring, originally less preferred, sites
was reduced within ca. 1000bp of the introduced preferred
cleavage site (20), suggesting that only one of two
neighbouring sites held by the same tetramer—the
preferred one—is cleaved eﬃciently in mode II activity.
The interference distance of around 1000bp to each side
of a preferred site agrees with the 952bp found by Reuter
et al. (44) as the distance limit for two sites in cis to be
bridged by an EcoRII dimer. Analysis of the EndoII struc-
ture (Andersson et al., manuscript in preparation) shows
that the enzyme needs to be distorted signiﬁcantly to
access both strands of a bound substrate, suggesting that
this distortion could induce a conformation preventing the
second dimer from incising its substrate and explaining
how only one of two bound sites is cleaved. No such con-
text eﬀects on cleavage have been observed in vitro (15).
However, in vitro double-strand breaks most frequently
result from two consecutive single-strand nicks resulting
from separate binding events (mode I activity), i.e. one
strand nicked per binding, rather than mode II concerted
cleavage of both strands in asingle binding event (5). Mode
II cleavage of only one of the bound substrates would be
in stark contrast to homotetrameric restriction endo-
nucleases binding two substrates, such as NgoMIV and
Cfr101, that cleave both substrates concertedly and swiftly,
likely concurrently rather than consecutively (45,46).
However, the limited double-stranded cleavage resulting
from EndoII activity in vivo is quite adequate to cause
degradation of host DNA by the very potent exonuclease
encoded or controlled by genes 46 and 47 (47), while
its predominant single-stranded nicking activity quite
possibly may promote recombination (Carlson and
Lagerba ¨ ck, unpublished). Thus, EndoII combines features
of both restriction and homing endonucleases with its own
unique mode of catalysis.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
FUNDING
Funding for open access charge: Departmental funds.
Conﬂict of interest statement. None declared.
REFERENCES
1. Carlson,K., Raleigh,E.A. and Hattman,S. (1994) In Karam,J.D.,
Drake,J.W., Kreuzer,K.N., Mosig,G., Hall,D.H., Eiserling,F.A.,
Black,L.W., Spicer,E.K., Kutter,E., Carlson,K. et al. (eds),
Molecular Biology of Bacteriophage T4. American Society for
Microbiology, Washington, DC, pp. 369–381.
2. Wyatt,G.R. and Cohen,S.S. (1953) The bases of the nucleic
acids of some bacterial and animal viruses: the occurrence of
5-hydroxymethylcytosine. Biochem. J., 55, 774–782.
3. Wyatt,G.R. and Cohen,S.S. (1952) A new pyrimidine base from
bacteriophage nucleic acids. Nature, 170, 1072–1073.
4. Lagerback,P. and Carlson,K. (2008) Amino acid residues in the
GIY-YIG endonuclease II of phage T4 aﬀecting sequence
recognition and binding as well as catalysis. J. Bacteriol., 190,
5533–5544.
5. Carlson,K., Lagerback,P. and Nystrom,A.C. (2004) Bacteriophage
T4 endonuclease II: concerted single-strand nicks yield
double-strand cleavage. Mol. Microbiol., 52, 1403–1411.
6. Kowalski,J.C., Belfort,M., Stapleton,M.A., Holpert,M.,
Dansereau,J.T., Pietrokovski,S., Baxter,S.M. and Derbyshire,V.
(1999) Conﬁguration of the catalytic GIY-YIG domain of intron
endonuclease I-TevI: coincidence of computational and molecular
ﬁndings. Nucleic Acids Res., 27, 2115–2125.
6182 Nucleic Acids Research, 2009, Vol. 37,No. 187. Dunin-Horkawicz,S., Feder,M. and Bujnicki,J.M. (2006)
Phylogenomic analysis of the GIY-YIG nuclease superfamily.
BMC Genomics, 7, 98.
8. Bryk,M., Quirk,S.M., Mueller,J.E., Loizos,N., Lawrence,C. and
Belfort,M. (1993) The td intron endonuclease I-TevI makes
extensive sequence-tolerant contacts across the minor groove of its
DNA target. EMBO J., 12, 4040–4041.
9. Mueller,J.E., Smith,D., Bryk,M. and Belfort,M. (1995) Intron-
encoded endonuclease I-TevI binds as a monomer to eﬀect
sequential cleavage via conformational changes in the td homing
site. EMBO J., 14, 5724–5735.
10. Orren,D.K. and Sancar,A. (1989) The (A)BC excinuclease of
Escherichia coli has only the UvrB and UvrC subunits in the
incision complex. Proc. Natl Acad. Sci. USA, 86, 5237–5241.
11. Verhoeven,E.E., Wyman,C., Moolenaar,G.F. and Goosen,N. (2002)
The presence of two UvrB subunits in the UvrAB complex
ensures damage detection in both DNA strands. EMBO J., 21,
4196–4205.
12. Tang,M., Nazimiec,M., Ye,X., Iyer,G.H., Eveleigh,J., Zheng,Y.,
Zhou,W. and Tang,Y.Y. (2001) Two forms of UvrC protein with
diﬀerent double-stranded DNA binding aﬃnities. J. Biol. Chem.,
276, 3904–3910.
13. Pertzev,A.V., Kravetz,A.N., Mayorov,S.G., Zakharova,M.V. and
Solonin,A.S. (1997) Isolation of a strain overproducing
endonuclease Eco29kI: puriﬁcation and characterization of the
homogeneous enzyme. Biochemistry, 62, 732–741.
14. Gasiunas,G., Sasnauskas,G., Tamulaitis,G., Urbanke,C.,
Razaniene,D. and Siksnys,V. (2008) Tetrameric restriction
enzymes: expansion to the GIY-YIG nuclease family. Nucleic Acids
Res., 36, 938–949.
15. Carlson,K., Kosturko,L.D. and Nystrom,A.C. (1999) Sequence-
speciﬁc cleavage by bacteriophage T4 endonuclease II in vitro. Mol.
Microbiol., 31, 1395–1405.
16. Oakley,B.R., Kirsch,D.R. and Morris,R. (1980) A Simpliﬁed
Ultrasensitive Silver Stain for Detecting Proteins in Polyacrylamide
Gels. Anal. Biochem., 105, 361–363.
17. Schultz,S.G. and Solomon,A.K. (1961) Cation transport in
Escherichia coli. I. Intracellular Na and K concentrations and net
cation movement. J. Gen. Physiol., 45, 355–369.
18. Carlson,K., Krabbe,M., Nystrom,A.C. and Kosturko,L.D. (1993)
DNA determinants of restriction. Bacteriophage T4 endonuclease
II-dependent cleavage of plasmid DNA in vivo. J. Biol. Chem., 268,
8908–8918.
19. Revzin,A., Ceglarek,J.A. and Garner,M.M. (1986) Comparison of
nucleic acid-protein interactions in solution and in polyacrylamide
gels. Anal. Biochem., 153, 172–177.
20. Carlson,K., Kosturko,L.D. and Nystrom,A.C. (1996) Short-range
and long-range context eﬀects on coliphage T4 endonuclease
II-dependent restriction. J. Bacteriol., 178, 6419–6426.
21. Pabo,C.O. and Sauer,R.T. (1984) Protein-DNA recognition.
Annu. Rev. Biochem., 53, 293–321.
22. Halford,S.E., Welsh,A.J. and Szczelkun,M.D. (2004)
Enzyme-mediated DNA looping. Annu. Rev. Biophys.
Biomol. Struct., 33, 1–24.
23. el-Deiry,W.S., Kern,S.E., Pietenpol,J.A., Kinzler,K.W. and
Vogelstein,B. (1992) Deﬁnition of a consensus binding site for p53.
Nat. Genet., 1, 45–49.
24. Raﬀerty,J.B., Sedelnikova,S.E., Hargreaves,D., Artymiuk,P.J.,
Baker,P.J., Sharples,G.J., Mahdi,A.A., Lloyd,R.G. and Rice,D.W.
(1996) Crystal structure of DNA recombination protein RuvA and
a model for its binding to the Holliday junction. Science, 274,
415–421.
25. Topal,M.D. and Conrad,M. (1993) Changing endonuclease EcoRII
Tyr308 to Phe abolishes cleavage but not recognition: possible
homology with the Int-family of recombinases. Nucleic Acids Res.,
21, 2599–2603.
26. Jo,K. and Topal,M.D. (1995) DNA topoisomerase and recombinase
activities in Nae I restriction endonuclease. Science, 267, 1817–1820.
27. Wentzell,L.M. and Halford,S.E. (1998) DNA looping by the Sﬁ I
restriction endonuclease. J. Mol. Biol., 281, 433–444.
28. Mucke,M., Grelle,G., Behlke,J., Kraft,R., Kruger,D.H. and
Reuter,M. (2002) EcoRII: a restriction enzyme evolving
recombination functions? EMBO J., 21, 5262–5268.
29. Yang,C.C. and Topal,M.D. (1992) Nonidentical DNA-binding sites
of endonuclease NaeI recognize diﬀerent families of sequences
ﬂanking the recognition site. Biochemistry, 31, 9657–9664.
30. Roberts,R.J., Belfort,M., Bestor,T., Bhagwat,A.S., Bickle,T.A.,
Bitinaite,J., Blumenthal,R.M., Degtyarev,S., Dryden,D.T.,
Dybvig,K. et al. (2003) A nomenclature for restriction enzymes,
DNA methyltransferases, homing endonucleases and their genes.
Nucleic Acids Res., 31, 1805–1812.
31. Wentzell,L.M., Nobbs,T.J. and Halford,S.E. (1995) The SﬁI
restriction endonuclease makes a four-strand DNA break at two
copies of its recognition sequence. J. Mol. Biol., 248, 581–595.
32. Siksnys,V., Grazulis,S. and Huber,R. (2004) Structure and function
of tetrameric restriction enzymes. In Pingoud,A. (ed.), Restriction
Endonucleases. Springer, Berlin, pp. 237–259.
33. Daniels,L.E., Wood,K.M., Scott,D.J. and Halford,S.E. (2003)
Subunit assembly for DNA cleavage by restriction endonuclease
SgrAI. J. Mol. Biol., 327, 579–591.
34. Zaremba,M., Sasnauskas,G., Urbanke,C. and Siksnys,V. (2005)
Conversion of the tetrameric restriction endonuclease Bse634I
into a dimer: oligomeric structure-stability-function correlations.
J. Mol. Biol., 348, 459–478.
35. Meisel,A., Mackeldanz,P., Bickle,T.A., Kruger,D.H. and
Schroeder,C. (1995) Type III restriction endonucleases translocate
DNA in a reaction driven by recognition site-speciﬁc ATP
hydrolysis. EMBO J., 14, 2958–2966.
36. Kong,H. and Smith,C.L. (1998) Does BcgI, a unique restriction
endonuclease, require two recognition sites for cleavage? Biol.
Chem., 379, 605–609.
37. Murray,N.E. (2000) Type I restriction systems: sophisticated
molecular machines (a legacy of Bertani and Weigle). Microbiol.
Mol. Biol. Rev., 64, 412–434.
38. Bath,A.J., Milsom,S.E., Gormley,N.A. and Halford,S.E. (2002)
Many type IIs restriction endonucleases interact with two recognition
sites before cleaving DNA. J. Biol. Chem., 277, 4024–4033.
39. Sutherland,E., Coe,L. and Raleigh,E.A. (1992) McrBC: a
multisubunit GTP-dependent restriction endonuclease. J. Mol. Biol.,
225, 327–348.
40. Ibryashkina,E.M., Zakharova,M.V., Baskunov,V.B.,
Bogdanova,E.S., Nagornykh,M.O., Den’mukhamedov,M.M.,
Melnik,B.S., Kolinski,A., Gront,D., Feder,M. et al. (2007) Type II
restriction endonuclease R.Eco29kI is a member of the GIY-YIG
nuclease superfamily. BMC Struct. Biol., 7, 48.
41. Edgell,D.R. and Shub,D.A. (2001) Related homing endonucleases
I-BmoI and I-TevI use diﬀerent strategies to cleave homologous
recognition sites. Proc. Natl Acad. Sci. USA, 98, 7898–7903.
42. Carter,J.M., Friedrich,N.C., Kleinstiver,B. and Edgell,D.R. (2007)
Strand-speciﬁc contacts and divalent metal ion regulate double-
strand break formation by the GIY-YIG Homing Endonuclease
I-BmoI. J. Mol. Biol., 374, 306–321.
43. Carlson,K. and Overvatn,A. (1986) Bacteriophage T4 endonucleases
II and IV, oppositely aﬀected by dCMP hydroxymethylase activity,
have diﬀerent roles in the degradation and in the RNA polymerase-
dependent replication of T4 cytosine-containing DNA. Genetics,
114, 669–685.
44. Reuter,M., Kupper,D., Meisel,A., Schroeder,C. and Kruger,D.H.
(1998) Cooperative binding properties of restriction endonuclease
EcoRII with DNA recognition sites. J. Biol. Chem., 273, 8294–8300.
45. Deibert,M., Grazulis,S., Sasnauskas,G., Siksnys,V. and Huber,R.
(2000) Structure of the tetrameric restriction endonuclease
NgoMIV in complex with cleaved DNA. Nat. Struct. Biol., 7,
792–799.
46. Embleton,M.L., Siksnys,V. and Halford,S.E. (2001) DNA cleavage
reactions by type II restriction enzymes that require two copies of
their recognition sites. J. Mol. Biol., 311, 503–514.
47. Kutter,E.M. and Wiberg,J.S. (1968) Degradation of cytosin-
containing bacterial and bacteriophage DNA after infection of
Escherichia coli B with bacteriophage T4D wild type and with
mutants defective in genes 46, 47 and 56. J. Mol. Biol., 38, 395–411.
Nucleic Acids Research, 2009,Vol.37, No. 18 6183